<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/305">
<title>Research articles</title>
<link>https://ir.cut.ac.zw:8080/xmlui/handle/123456789/305</link>
<description>Research publications</description>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/746"/>
<rdf:li rdf:resource="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/713"/>
<rdf:li rdf:resource="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/686"/>
<rdf:li rdf:resource="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/685"/>
</rdf:Seq>
</items>
<dc:date>2026-06-06T04:29:44Z</dc:date>
</channel>
<item rdf:about="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/746">
<title>Chemical composition by PTP 1B inhibitory activity guided analysis of a plantbased antidiabetic polyherbal drug used in ethnomedical systems</title>
<link>https://ir.cut.ac.zw:8080/xmlui/handle/123456789/746</link>
<description>Chemical composition by PTP 1B inhibitory activity guided analysis of a plantbased antidiabetic polyherbal drug used in ethnomedical systems
Mugari, Pardon; Dzomba, Pamhidzai; Nyoni, Stephen
Background Due to growing resistance and continued depletion of drugs that can be used as replacements, people&#13;
turn to herbal antidiabetic medicines. A polyherbal drug consisting of a mixture of two herbal plants, Zanthoxylum&#13;
chalybeum and Xeroderris stuhlmannii root powder mixed in equal amounts using a tea cup, was studied to investigate&#13;
its chemical composition and possible mode of action.&#13;
Methods Phytochemicals were isolated using Column and Thin Layer Chromatography, and antidiabetic activity&#13;
was ascertained using an enzyme inhibition model. Active compounds identity was established using 1HNMR,&#13;
13CNMR, HSQC-NMR, UV, FT-IR and MS spectroscopy.&#13;
Results Results showed that the polyherbal drug consisted of two alkaloids and three anthocyanins as the major&#13;
active components. PTP 1B inhibition of alkaloids was not significantly different from that of metformin with percentage&#13;
inhibition of 78.6 ± 3.2 and 79.6 ± 2.3%. The anthocyanins inhibited PTP 1B enzyme significantly better&#13;
than metformin with percentage inhibition of 88.2 ± 3.2, 90.3 ± 2.3 and 93.6 ± 2.9%. One new compound, an alkaloid, 1,&#13;
2-dimethoxy-12-methyl-7-(3-methylbut-2-en-1-yl)-12, 13-dihydro [1,3] benzodioxolo [5,6-c] phenanthridin-13-ol, one&#13;
previously reported alkaloid berberine, IUPAC name, 9,10-dimethoxy-5,6-dihydro[1,3] dioxolo [4’,5’:6,7] isoquinolino&#13;
[2,1-b][2] benzazin-7-ium and three anthocyanins,, malvidin 3-o-glucoside, pelargonidin-3-O-gucoside and malvidin&#13;
3, 5-O-diglucoside were identified as the active compounds in the polyherbal drug extract.&#13;
Conclusion Presence of alkaloids and anthocyanins that have PTP 1B inhibitory activity showed that the polyherbal&#13;
drug is a potential medicine for managing diabetes.
</description>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/713">
<title>In Silico, In Vitro, and In Vivo Antidiabetic Activity of an Alkaloid, 1, 2-Dimethoxy-12-Methyl-7-(3-Methylbut-2-en-1- yl)-12, 13-Dihydro [1,3] Benzodioxolo [5,6-c] Phenanthridin- 13-ol, Isolated From a Zimbabwean Herbal Antidiabetic Medicine</title>
<link>https://ir.cut.ac.zw:8080/xmlui/handle/123456789/713</link>
<description>In Silico, In Vitro, and In Vivo Antidiabetic Activity of an Alkaloid, 1, 2-Dimethoxy-12-Methyl-7-(3-Methylbut-2-en-1- yl)-12, 13-Dihydro [1,3] Benzodioxolo [5,6-c] Phenanthridin- 13-ol, Isolated From a Zimbabwean Herbal Antidiabetic Medicine
Dzomba, Pamhidzai; Mugari, Pardon; Nyoni, Stephen; Mudewairi, Elias
Protein tyrosine phosphatase 1B (PTP1B) is a crucial drug target for treating diabetes mellitus Type 2 (DMT2) because of its&#13;
link to insulin resistance. Currently there are no approved clinical drugs targeting PTP1B. Therefore, the present study was&#13;
aimed at investigating the mode of action of an alkaloid, 1, 2-dimethoxy-12-methyl-7-(3-methylbut-2-en-1-yl)-12, 13-dihydro [1,3]&#13;
benzodioxolo [5,6-c] phenanthridin-13-ol (1, 2 DMMDBP), previously isolated from a popular Zimbabwean antidiabetic herbal&#13;
medicine. Molecular docking studies using PDB, 2QBP (catalytic site) and IT48 (allosteric site), in vitro PTP1B enzyme inhibition,&#13;
and in vivo assays using streptozotocin induced diabetic rats were applied to investigate antidiabetic effect. Drug-like and toxicity&#13;
properties were evaluated using SwissADME and Protox 3.0 webservers, respectively. Molecular docking results showed that&#13;
the test compound (1, 2 DMMDBP) has a greater binding affinity (11.1 kcal/mol, rmsd, 0.000 Å) for the allosteric site than the&#13;
catalytic site (9.6 kcal/mol, rmsd, 0.000 Å). In vitro inhibition assay showed that 1, 2 DMMDBP was more potent (IC50 = 1.10  M&#13;
) than that of ursolic acid (IC50 = 7.13  M). Additionally, in in vivo studies, 1, 2 DMMDBP maintained normal hypoglycemia&#13;
and mass better than the reference drug metformin. In absorption, distribution, metabolism, and excretion predictive studies,&#13;
1, 2 DMMDBP showed good drug-like properties. It did not violate any of Lipinski's classic rules. It showed good physicochemical properties such as absorption, (log of skin permeability (log Kp) value was −4.95), bioavailability with a score of 0.55 and&#13;
biotransformation by cytochrome-P enzymes CYP1A2 and CYP3A4. Protox 3.0 webserver predicted LD50 value of 1000 mg/kg,&#13;
showing that it may be toxic if swallowed. Based on the evidence presented, 1, 2 DMMDBP is a highly promising compound in&#13;
the development of potent and selective allosteric modulator drugs of PTP1B for the treatment of DMT2 upon further studies.
</description>
<dc:date>2026-02-14T00:00:00Z</dc:date>
</item>
<item rdf:about="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/686">
<title>Comparative electrocatalytic studies of nanocomposites of mixed and covalently linked multiwalled carbon nanotubes and 4-(4,6- diaminopyrimidin-2-ylthio) phthalocyaninato cobalt(II)</title>
<link>https://ir.cut.ac.zw:8080/xmlui/handle/123456789/686</link>
<description>Comparative electrocatalytic studies of nanocomposites of mixed and covalently linked multiwalled carbon nanotubes and 4-(4,6- diaminopyrimidin-2-ylthio) phthalocyaninato cobalt(II)
Nyoni, Stephen; Nyokong, Tebello
Electrocatalytic behavior of 4-(4,6-diaminopyrimidin-2-ylthio) phthalocyaninato cobalt(II) (CoPyPc)&#13;
when mixed or covalently mixed to multiwalled carbon nanotubes (MWCNTs) is reported. Infra-red spectroscopy&#13;
was used to confirm amide linkage of the covalently linked nanocomposite. Rotating disk electrode&#13;
(RDE) and cyclic (CV) voltammetry studies were used for the electrochemical characterization of&#13;
the prepared phthalocyanine and MWCNT nanocomposite. The electrocatalytic effects of the nanocomposites&#13;
of the cobalt phthalocyanine derivative were then investigated towards L-cysteine oxidation using&#13;
both RDE and CV experiments, and the electrocatalytic performance of the covalently linked cobalt&#13;
phthalocyanine-MWCNT was found to be superior over the mixed nanocomposite.
</description>
<dc:date>2015-05-28T00:00:00Z</dc:date>
</item>
<item rdf:about="https://ir.cut.ac.zw:8080/xmlui/handle/123456789/685">
<title>Electrocatalytic behahiour of cobalt tetraamino-phthalocyanine in thepresence of a composite of reduced graphene nanosheets and ofmulti-walled carbon nanotubes</title>
<link>https://ir.cut.ac.zw:8080/xmlui/handle/123456789/685</link>
<description>Electrocatalytic behahiour of cobalt tetraamino-phthalocyanine in thepresence of a composite of reduced graphene nanosheets and ofmulti-walled carbon nanotubes
Nyoni, Stephen; Nyokong, Tebello
A composite of multi-walled carbon nanotubes (MWCNT) with reduced graphene nanosheets (rGNS-2)was developed in order to minimize the restacking of the latter. The composite was used to modify a glassycarbon electrode (GCE). GCE was further modified with cobalt tetraamino phthalocyanine (CoTAPc). Themodified electrode is represented as rGNS-2-MWCNT-CoTAPc-GCE. X-ray photoelectron spectroscopy,transmission electron microscopy, scanning electrochemical microscopy and Raman spectroscopy wereused to explore into surface functionalities, morphology and topography of the nanocomposite. The rGNS-2-MWCNT-CoTAPc-GCE had a low limit of detection of 3.32 × 10−8M towards the detection of paraguatas a test analyte. A mechanism for paraquat detection using an rGNS-2-MWCNT-CoTAPc-GCE is alsoproposed in this work
</description>
<dc:date>2014-05-18T00:00:00Z</dc:date>
</item>
</rdf:RDF>
